Does TINZAPARIN Cause Malignant neoplasm progression? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with TINZAPARIN. This represents 0.4% of all adverse event reports for TINZAPARIN.
7
Reports of Malignant neoplasm progression with TINZAPARIN
0.4%
of all TINZAPARIN reports
5
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TINZAPARIN?
Of the 7 reports, 5 (71.4%) resulted in death, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TINZAPARIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TINZAPARIN Cause?
Acute kidney injury (135)
Anaemia (118)
Off label use (110)
Maternal exposure during pregnancy (108)
Thrombocytopenia (86)
Drug ineffective (82)
Toxic epidermal necrolysis (80)
Hepatocellular injury (70)
Premature baby (70)
Cholestasis (67)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TINZAPARIN Alternatives Have Lower Malignant neoplasm progression Risk?
TINZAPARIN vs TIOCONAZOLE
TINZAPARIN vs TIOPRONIN
TINZAPARIN vs TIOTROPIUM
TINZAPARIN vs TIPIRACIL\TRIFLURIDINE
TINZAPARIN vs TIPRANAVIR